These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 190707)
1. Effects of diphenylhydantoin in 41 epileptics institutionalized since childhood. Herberg KP South Med J; 1977 Jan; 70(1):19-24. PubMed ID: 190707 [TBL] [Abstract][Full Text] [Related]
2. Side effects of antiepileptic drugs: a peripheral neuropathy due to diphenylhydantoin (DPH) intoxication. Uchigata M; Nozawa T; Shiozawa R; Tanabe H Folia Psychiatr Neurol Jpn; 1980; 34(3):314-5. PubMed ID: 6260604 [No Abstract] [Full Text] [Related]
3. Problems with the use of conventional anticonvulsant drugs in mentally retarded individuals. Schain RJ Brain Dev; 1979; 1(2):77-82. PubMed ID: 552214 [TBL] [Abstract][Full Text] [Related]
4. Cerebellar atrophy in phenytoin-treated mentally retarded epileptics. Iivanainen M; Viukari M; Helle EP Epilepsia; 1977 Sep; 18(3):375-86. PubMed ID: 891491 [TBL] [Abstract][Full Text] [Related]
5. Electroencephalography and phenytoin toxicity in mentally retarded epileptic patients. Iivanainen M; Viukari M; Seppäläinen AM; Helle EP J Neurol Neurosurg Psychiatry; 1978 Mar; 41(3):272-7. PubMed ID: 632825 [TBL] [Abstract][Full Text] [Related]
6. Plasma level distribution, effect and toxicity of antiepileptic drugs among Ethiopian epileptics. Bekele G; Abebe Y; T'Haimanot R Ethiop Med J; 1990 Jan; 28(1):23-30. PubMed ID: 2307155 [TBL] [Abstract][Full Text] [Related]
7. Chronic diphenyl hydantoin encephalopathy in mentally retarded children and adolescent with severe epilepsy. Meistrup-Larsen KI; Hermann S; Permin H Acta Neurol Scand; 1979 Jul; 60(1):50-5. PubMed ID: 495042 [TBL] [Abstract][Full Text] [Related]
8. Effect of diphenylhydantoin therapy on folate metabolism of mentally retarded epileptics. Arakawa T; Yoshida T; Honda Y; Narisawa K; Hirono H Tohoku J Exp Med; 1973 May; 110(1):59-68. PubMed ID: 4729235 [No Abstract] [Full Text] [Related]
9. Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin. Mauguière F; Dalery J; de Villard R; Courjon J Eur Neurol; 1979; 18(2):116-23. PubMed ID: 456389 [TBL] [Abstract][Full Text] [Related]
10. Diphenylhydantoin as an anticonvulsant: protein binding and fluctuation of the serum and cerebrospinal fluid levels in forty mentally subnormal epileptics. Viukari NM; Tammisto P J Ment Defic Res; 1969 Dec; 13(4):235-44. PubMed ID: 4983146 [No Abstract] [Full Text] [Related]
11. Delayed and insidious onset of diphenylhydantoin toxicity. Herberg KP South Med J; 1975 Jan; 68(1):70-5. PubMed ID: 1154062 [No Abstract] [Full Text] [Related]
12. Motor nerve conduction study in patients on diphenylhydantoin therapy. Chokroverty S; Sayeed ZA J Neurol Neurosurg Psychiatry; 1975 Dec; 38(12):1235-9. PubMed ID: 176326 [TBL] [Abstract][Full Text] [Related]